Compare Stocks: AMBBY, GMED, GKOS, and PODD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMBBY Ambu A/S	$11.64	$10.97	$8.55 ▼ $16.31	$2.74B	0.92	24 shs	N/A
GKOS Glaukos	$179.02 +0.1%	$171.35	$73.16 ▼ $191.62	$10.56B	0.69	1.00 million shs	961,189 shs
GMED Globus Medical	$81.48 +0.1%	$78.03	$59.51 ▼ $101.40	$10.94B	0.96	1.44 million shs	768,420 shs
PODD Insulet	$149.01	$140.58	$126.40 ▼ $354.88	$10.33B	1.11	1.64 million shs	802,949 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMBBY Ambu A/S	0.00%	0.00%	+13.84%	+10.75%	-28.63%
GKOS Glaukos	0.00%	+8.86%	+15.84%	+17.72%	+139.97%
GMED Globus Medical	0.00%	+6.31%	+9.27%	+4.09%	+30.66%
PODD Insulet	0.00%	+5.61%	+9.46%	-9.69%	-53.57%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMBBY Ambu A/S	$11.64	$10.97	$8.55 ▼ $16.31	$2.74B	0.92	24 shs	N/A
GKOS Glaukos	$179.02 +0.1%	$171.35	$73.16 ▼ $191.62	$10.56B	0.69	1.00 million shs	961,189 shs
GMED Globus Medical	$81.48 +0.1%	$78.03	$59.51 ▼ $101.40	$10.94B	0.96	1.44 million shs	768,420 shs
PODD Insulet	$149.01	$140.58	$126.40 ▼ $354.88	$10.33B	1.11	1.64 million shs	802,949 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMBBY Ambu A/S	0.00%	0.00%	+13.84%	+10.75%	-28.63%
GKOS Glaukos	0.00%	+8.86%	+15.84%	+17.72%	+139.97%
GMED Globus Medical	0.00%	+6.31%	+9.27%	+4.09%	+30.66%
PODD Insulet	0.00%	+5.61%	+9.46%	-9.69%	-53.57%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMBBY Ambu A/S	2.00	Hold	N/A	N/A
GKOS Glaukos	2.80	Moderate Buy	$181.43	1.34% Upside
GMED Globus Medical	2.88	Moderate Buy	$99.46	22.08% Upside
PODD Insulet	2.46	Hold	$186.68	25.28% Upside

Current Analyst Ratings Breakdown

Latest AMBBY, GMED, GKOS, and PODD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	GKOS Glaukos	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/13/2026	GKOS Glaukos	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$190.00
10/12/2026	PODD Insulet	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$275.00 ➝ $190.00
10/12/2026	GKOS Glaukos	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$202.00 ➝ $205.00
10/9/2026	GMED Globus Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Hold (C+)
10/7/2026	PODD Insulet	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold
10/6/2026	PODD Insulet	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Underweight ➝ Equal Weight	$150.00
10/1/2026	GMED Globus Medical	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Outperform	$115.00 ➝ $85.00
9/22/2026	GKOS Glaukos	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$190.00 ➝ $210.00
9/21/2026	PODD Insulet	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D+)
9/18/2026	GMED Globus Medical	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral

(Data available from 10/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMBBY Ambu A/S	$894.37M	3.06	$0.62 per share	18.82	$3.80 per share	3.06
GKOS Glaukos	$507.44M	20.81	N/A	N/A	$11.42 per share	15.68
GMED Globus Medical	$2.94B	3.72	$6.29 per share	12.96	$33.86 per share	2.41
PODD Insulet	$2.71B	3.82	$6.32 per share	23.57	$21.54 per share	6.92

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMBBY Ambu A/S	$90.19M	$0.30	38.80	N/A	N/A	8.18%	8.49%	6.75%	N/A
GKOS Glaukos	-$187.69M	-$3.25	N/A	325.50	N/A	-30.68%	-6.37%	-4.78%	10/28/2026 (Confirmed)
GMED Globus Medical	$537.87M	$3.91	20.84	15.12	1.31	17.02%	14.57%	12.62%	11/5/2026 (Estimated)
PODD Insulet	$247.10M	$5.35	27.85	19.33	1.17	12.29%	29.29%	13.31%	11/4/2026 (Confirmed)

Latest AMBBY, GMED, GKOS, and PODD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	GMED Globus Medical	$1.20	N/A	N/A	N/A	$792.45 million	N/A
11/4/2026	Q3 2026	PODD Insulet	$1.59	N/A	N/A	N/A	$832.71 million	N/A
10/28/2026	Q3 2026	GKOS Glaukos	-$0.0964	N/A	N/A	N/A	$168.04 million	N/A
8/25/2026	Q3 2026	AMBBY Ambu A/S	N/A	$0.09	N/A	$0.09	N/A	$255.12 million
8/6/2026	Q2 2026	GMED Globus Medical	$1.10	$1.34	+$0.24	$1.10	$782.88 million	$789.61 million
8/5/2026	Q2 2026	PODD Insulet	$1.47	$1.66	+$0.19	$1.37	$787.39 million	$801.70 million
7/29/2026	Q2 2026	GKOS Glaukos	-$0.2105	-$0.14	+$0.0705	-$0.31	$150.93 million	$185.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMBBY Ambu A/S	$0.03	0.26%	N/A	10.00%	N/A
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMBBY Ambu A/S	0.08	2.77	1.69
GKOS Glaukos	0.10	5.04	4.46
GMED Globus Medical	N/A	4.62	2.93
PODD Insulet	0.65	2.48	1.83

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMBBY Ambu A/S	N/A
GKOS Glaukos	99.04%
GMED Globus Medical	95.16%
PODD Insulet	N/A

Insider Ownership

Company	Insider Ownership
AMBBY Ambu A/S	N/A
GKOS Glaukos	5.90%
GMED Globus Medical	18.38%
PODD Insulet	0.36%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMBBY Ambu A/S	5,384	234.97 million	N/A	Not Optionable
GKOS Glaukos	1,094	58.98 million	55.50 million	Optionable
GMED Globus Medical	6,000	134.26 million	109.59 million	Optionable
PODD Insulet	5,400	69.35 million	69.10 million	Optionable

AMBBY, GMED, GKOS, and PODD Headlines

Recent News About These Companies

Insulet Corporation (PODD) - What Are Researchers Saying About This Stock?

October 25 at 4:43 AM | marketbeat.com

Insulet Corporation $PODD Stock Sold by Sumitomo Mitsui DS Asset Management Company Ltd

October 25 at 4:39 AM | marketbeat.com

Insulet (NASDAQ:PODD) Rating Lowered to "Hold" at Wall Street Zen

October 24 at 4:06 AM | marketbeat.com

Insulet Corporation $PODD Stock: Counterpoint Mutual Funds LLC Lowers Holdings

October 20, 2026 | marketbeat.com

2 Profitable Stocks to Keep an Eye On and 1 We Question

October 19, 2026 | finance.yahoo.com

Insulet Corporation $PODD Shares Sold by Curated Wealth Partners LLC

October 18, 2026 | marketbeat.com

Insulet Corporation $PODD Shares Acquired by Assenagon Asset Management S.A.

October 18, 2026 | marketbeat.com

Here's Why Insulet (PODD) is a Strong Growth Stock

October 16, 2026 | zacks.com

Insulet (PODD) Gets a Hold from Leerink Partners

October 14, 2026 | theglobeandmail.com

Insulet (NASDAQ:PODD) Stock Sale Reported by Rep. Gilbert Ray Cisneros, Jr.

October 14, 2026 | marketbeat.com

Insulet’s Omnipod Discover data platform begins full US rollout

October 13, 2026 | massdevice.com

Insulet Announces Omnipod Discover Now Available in U.S.

October 12, 2026 | businesswire.com

Insulet (NASDAQ:PODD) Stock Bumped Up to "Buy" by Wall Street Zen

October 10, 2026 | marketbeat.com

Barclays initiates coverage of Insulet with equal-weight rating

October 8, 2026 | msn.com

Insulet (NASDAQ:PODD) Upgraded to Hold at Barclays

October 8, 2026 | marketbeat.com

Analysts Offer Insights on NA Companies: Insulet (PODD) and General Motors (GM)

October 1, 2026 | theglobeandmail.com

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

October 1, 2026 | finance.yahoo.com

Insulet Corporation (NASDAQ:PODD) Stock Has Consensus Target Price of $195.40

September 30, 2026 | marketbeat.com

Insulet Sees Emerging Headwinds From New Market Entrants in 2027, 2028, Oppenheimer Says

September 28, 2026 | finance.yahoo.com

Insulet Sees Emerging Headwinds From New Market Entrants in 2027, 2028, Oppenheimer Says

September 28, 2026 | finance.yahoo.com

Insulet (PODD) Stock May Trade At A Discount To Fair Value

September 26, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMBBY, GMED, GKOS, and PODD Company Descriptions

Ambu A/S OTCMKTS:AMBBY

$11.64 0.00 (0.00%)

As of 10/23/2026

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

Glaukos NYSE:GKOS

$179.02 +0.14 (+0.08%)

Closing price 10/23/2026 03:59 PM Eastern

Extended Trading

$178.88 -0.14 (-0.08%)

As of 10/23/2026 07:30 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Globus Medical NYSE:GMED

$81.47 +0.07 (+0.08%)

Closing price 10/23/2026 03:59 PM Eastern

Extended Trading

$81.42 -0.05 (-0.06%)

As of 10/23/2026 07:30 PM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Insulet NASDAQ:PODD

$149.01 0.00 (0.00%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$147.37 -1.64 (-1.10%)

As of 10/23/2026 07:40 PM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMBBY, GMED, GKOS, and PODD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMBBY, GMED, GKOS, and PODD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMBBY, GMED, GKOS, and PODD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMBBY, GMED, GKOS, and PODD Company Descriptions

Ambu A/S OTCMKTS:AMBBY

Glaukos NYSE:GKOS

Globus Medical NYSE:GMED

Insulet NASDAQ:PODD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMBBY, GMED, GKOS, and PODD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMBBY, GMED, GKOS, and PODD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMBBY, GMED, GKOS, and PODD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMBBY, GMED, GKOS, and PODD Company Descriptions

Ambu A/S OTCMKTS:AMBBY

Glaukos NYSE:GKOS

Globus Medical NYSE:GMED

Insulet NASDAQ:PODD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools